AA
NEO icon

Ancora Advisors’s NeoGenomics NEO Stock Holding History

Ancora Advisors’s Portfolio NEO Stock Details NEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-17,928
Closed -$226K – 613
2018
Q4 		$226K Buy
17,928
+1,103
+7% +$16.4K 0.01% 538
2018
Q3 		$258K Sell
16,825
-19,060
-53% -$263K 0.01% 610
2018
Q2 		$470K Buy
35,885
+25,858
+258% +$285K 0.02% 497
2018
Q1 		$82K Buy
+10,027
New +$81.2K ﹤0.01% 657
2017
Q1 		– Sell
-2,470
Closed -$21K – 927
2016
Q4 		$21K Buy
+2,470
New +$21.2K ﹤0.01% 929
2014
Q2 		– Sell
-13,000
Closed -$45K – 490
2014
Q1 		$45K Buy
13,000
+3,000
+30% +$11.2K 0.01% 446
2013
Q4 		$36K Buy
+10,000
New +$34.7K 0.01% 417

Other funds holding NEO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CTA
Carillon Tower Advisers St. Petersburg, Florida $16.4B AUM 64.75% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $4.25B AUM 141.71% 1-Year Est. Return
EMFAT
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.85B AUM 140.52% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Ancora Advisors's NEO Position: Q1 2019 in Review

Ancora Advisors sold out of NeoGenomics (NEO) in Q1 2019, closing a stake of 17,928 shares — an estimated $226K sold.

Ancora Advisors first reported a position in NEO in Q4 2013 and held it in 7 quarters. The position peaked at $470K in Q2 2018. 235 funds tracked by Wall St. Rank hold NEO as of Q1 2019.

  • Ancora Advisors reported no remaining NeoGenomics position as of Q1 2019 after selling out during the quarter.
  • Ancora Advisors sold 17,928 NeoGenomics shares in Q1 2019, an estimated $226K.
  • Ancora Advisors first reported a position in NeoGenomics in Q4 2013 and held it in 7 quarters.
  • Ancora Advisors's NeoGenomics position peaked at $470K in Q2 2018.
  • 235 funds tracked by Wall St. Rank held NeoGenomics as of Q1 2019.

Based on Ancora Advisors's 13F filing for Q1 2019, filed 15 May 2019.